Metraipolis › archive › dc_0359083947cb

Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025 — Europe PMC PMID:41320971

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41320971
DOI
10.1111/irv.70186
License (as archived)
solo-consultazione
Archived
2026-11-08T01:39:46.507Z
SHA-256 of the archived text
410ad3a74dfceb95ca00cc3425fdd6979c41ffe1cde5206e4572341799780641
Stable URL of this page
https://metraipolis.com/documento/dc_0359083947cb

How to cite

Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025 — Europe PMC PMID:41320971 — Europe PMC (en), https://europepmc.org/article/MED/41320971 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0359083947cb (Metraipolis archive dc_0359083947cb, sha256 410ad3a74dfceb95ca00cc3425fdd6979c41ffe1cde5206e4572341799780641)
BibTeX
@misc{dc0359083947cb,
  title = {Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025 — Europe PMC PMID:41320971},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41320971},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0359083947cb; sha256 410ad3a74dfceb95ca00cc3425fdd6979c41ffe1cde5206e4572341799780641},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41320971. Agents can read the archived copy with the MCP tool read_document.